on Mainz BioMed N.V.
Mainz Biomed to Participate in GARPS 2025 Conference
Mainz Biomed N.V., a molecular genetics diagnostics company, will attend the 38th Annual Meeting of the Gastroenterological Working Group of Rhineland-Palatinate (GARPS) on November 14-15, 2025, in Bad Kreuznach, Germany. This event unites experts in gastroenterology and hepatology, fostering knowledge exchange across the Rhineland-Palatinate region.
The conference will enable Mainz Biomed to engage with key opinion leaders in gastroenterology and discuss advancements in cancer prevention. The company plans to present its flagship product, ColoAlert®, a diagnostic test for early detection of colorectal cancer, and explore potential collaborations with healthcare professionals.
Attendees are invited to visit Mainz Biomed's booth to learn more about the significance of early colorectal cancer detection and to discuss collaboration opportunities.
R. H.
Copyright © 2025 FinanzWire, all reproduction and representation rights reserved.
Disclaimer: although drawn from the best sources, the information and analyzes disseminated by FinanzWire are provided for informational purposes only and in no way constitute an incentive to take a position on the financial markets.
Click here to consult the press release on which this article is based
See all Mainz BioMed N.V. news